AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes
AUAUniversity5 Heinä 2023

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc.

Jaksot(423)

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

2018 AUA Annual Meeting Presidential Address J. Brantley Thrasher, MD, FACS Department of Urology, University of Kansas Health System

21 Tammi 202019min

AUA2017 Presidential Address: Urology: A Personal Perspective

AUA2017 Presidential Address: Urology: A Personal Perspective

2017 AUA Annual Meeting Presidential Address Urology: A Personal Perspective Richard K. Babayan, MD, FACS

14 Tammi 202023min

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

2016 AUA Annual Meeting Presidential Address William F. Gee, MD Lexington, KY

8 Tammi 202020min

Targeted Therapies In Renal Cell Carcinoma

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of...

24 Joulu 201933min

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual p...

18 Joulu 201937min

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological age...

11 Joulu 201927min

Adjuvant Therapy in Renal Cell Carcinoma

Adjuvant Therapy in Renal Cell Carcinoma

Co-Host: Alexander Kutikov, MD, FACS At the conclusion of these activities, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC. 2. Identify b...

4 Joulu 201932min

Comorbidities in Advanced Prostate Cancer

Comorbidities in Advanced Prostate Cancer

Co-Host: Alicia K. Morgans, MD, MPH At the conclusion of these activities, participants will be able to: 1. Recognize cardiovascular comorbidities and describe their management in the context of pros...

27 Marras 201928min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
rss-liian-kuuma-peruna
rss-vapaudu-voimaasi
rss-hereilla
dear-ladies
rss-uskonto-on-tylsaa
rss-valo-minussa-2
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
adhd-podi
aloita-meditaatio
kesken
psykologia
rss-duodecim-lehti
esa-saarinen-filosofia-ja-systeemiajattelu